# Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption in GBM Patients

> **NCT04998864** · — · COMPLETED · sponsor: **InSightec** · enrollment: 3 (actual)

## Conditions studied

- Glioma, Malignant
- Glioblastoma

## Interventions

- **DEVICE:** Magnetic Resonance guided Focused ultrasound (MRgFUS)

## Key facts

- **NCT ID:** NCT04998864
- **Lead sponsor:** InSightec
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-25
- **Primary completion:** 2023-07-27
- **Final completion:** 2023-10-12
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2026-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04998864

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04998864, "Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption in GBM Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04998864. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*